Yarrow Bioscience, Inc.
YARWReported to SECin USCIK 0001566044Filings at SEC EDGAR
No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.
This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 10. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.
The most recent filings
Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.
| Filed by | Type | Value | Reported | Filed by | Value | Type | Shares | Reported |
|---|---|---|---|---|---|---|---|---|
| Ashiya Mona— | Award | nothing paid15,435 shares | Jul 29, 2026 | Ashiya Mona | nothing paid | Award | 15,435 | Jul 29, 2026 |
| Zeronda Tyler— | Award | nothing paid185,798 shares | Jul 29, 2026 | Zeronda Tyler | nothing paid | Award | 185,798 | Jul 29, 2026 |
| Zeronda TylerCHIEF FINANCIAL OFFICER | Administrative | $20,21022,516 shares | Jul 24, 2026 | Zeronda TylerCHIEF FINANCIAL OFFICER | $20,210 | Administrative | 22,516 | Jul 24, 2026 |
| Harsch MutyaCHIEF LEGAL OFFICER AND GC | Administrative | $20,21022,516 shares | Jul 24, 2026 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | $20,210 | Administrative | 22,516 | Jul 24, 2026 |
| Domzalski DavidPRESIDENT AND CEO | Administrative | $71,26179,391 shares | Jul 24, 2026 | Domzalski DavidPRESIDENT AND CEO | $71,261 | Administrative | 79,391 | Jul 24, 2026 |